A current model for predicting the risk of cardiovascular diseases in patients with type 2 diabetes mellitus

被引：0
|
作者：
Biryukova, E. V. [1 ]
机构：
[1] Moscow State Univ Med & Dent, Minist Hlth & Social Dev Russia, Moscow, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2012年 / 84卷 / 10期
关键词：
type 2 diabetes mellitus; ADVANCE trial; cardiovascular risk prediction scale; sugar-lowering therapy; BLOOD-GLUCOSE CONTROL; OUTCOMES; COMPLICATIONS; PREVALENCE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Type 2 diabetes mellitus (T2DM) is a severe progressive disease complicating the development of micro- and macrovascular complications that result in early disability, including that in able-bodied persons, a reduction in the patients' life, and its worse quality. The author discusses the new scale developed according to the results of the ADVANCE trial for predicting the cardiovascular risk in patients with T2DM which may be used widely in these patients to estimate the risk of cardiovascular events and as a tool to assist in determining the intensity of treatment. She considers current approaches to treating T2DM, by using the results of the ADVANCE trial.
引用
收藏
页码：98 / 102
页数：5
相关论文
共 50 条
  • [21] Osteprotegerin as cardiovascular risk marker in patients with type 2 diabetes mellitus
    Rozas-Moreno, P.
    Munoz-Torres, M.
    Alonso, G.
    Fernandez-Garcia, D.
    Luque-Fernandez, I.
    Sebastian-Ochoa, A.
    Escobar-Jimenez, F.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S271 - S271
  • [22] Reducing Global Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus
    Gavin, James R., III
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2008, 108 (05): : S14 - S19
  • [23] Cardiovascular risk of sitagliptin in treating patients with type 2 diabetes mellitus
    Zeng, De-kang
    Xiao, Qian
    Li, Fa-qi
    Tang, Yu-zhi
    Jia, Chao-li
    Tang, Xue-wen
    BIOSCIENCE REPORTS, 2019, 39
  • [24] Assessment of Cardiovascular Risk Factors in Patients With Type 2 Diabetes Mellitus
    Ramona, Dragut R.
    Rusu, Emilia
    Radulian, Gabriela
    Parpala, Cristina
    Popescu, Horatiu
    Nan, Raluca
    DIABETES, 2012, 61 : A562 - A563
  • [25] Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases
    Bashier, Alaaeldin
    Bin Hussain, Azza
    Abdelgadir, Elamin
    Alawadi, Fatheya
    Sabbour, Hani
    Chilton, Robert
    DIABETOLOGY & METABOLIC SYNDROME, 2019, 11 (01):
  • [26] Use of Troponin as a predictor for cardiovascular diseases in patients with type 2 Diabetes Mellitus
    Bellia, Chiara
    Lombardo, Mauro
    Della-Morte, David
    CLINICA CHIMICA ACTA, 2020, 507 : 54 - 61
  • [27] Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases
    Alaaeldin Bashier
    Azza Bin Hussain
    Elamin Abdelgadir
    Fatheya Alawadi
    Hani Sabbour
    Robert Chilton
    Diabetology & Metabolic Syndrome, 11
  • [28] Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
    Inzucchi, Silvio E.
    Wanner, Christoph
    Lachin, John M.
    Fitchett, David
    Bluhmki, Erich
    Hantel, Stefan
    Mattheus, Michaela
    Devins, Theresa
    Johansen, Odd Erik
    Woerle, Hans Juergen
    Broedl, Uli C.
    Zinman, Bernard
    CIRCULATION, 2015, 132 (23) : 2271 - 2271
  • [29] Cardiovascular risk factors in patients of type 2 diabetes mellitus with and without cardiovascular complications
    Aasvee, KE
    Kurvinen, E
    Roovere, T
    Tupits, H
    Hedman, A
    Jauhiainen, M
    Sundvall, J
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 152 - 152
  • [30] Elevated plasma homocysteine in type 2 diabetes mellitus: a risk factor for cardiovascular diseases
    Ebesunun, Maria Onomhaguan
    Obajobi, Esther Odunayo
    PAN AFRICAN MEDICAL JOURNAL, 2012, 12
12345